News
Startek Sets Second Quarter 2022 Conference Call for Monday, August 8, 2022 at 5 p.m. ET
Startek, Inc. (NYSE: SRT), a global customer experience (CX) solutions provider, will hold a conference call on Monday, August 8, 2022 at 5 p.m. ET to discuss its financial results for the second
Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Novocure today announced the recipients of the 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program. The AACR-Novocure Grants for Tumor Treating Fields Research Program
Farmers National Banc Corp. Reports 2022 Second Quarter Results
Farmers National Banc Corp. (“Farmers” or the “Company”) (NASDAQ: FMNB) today reported second quarter net income of $16.0 million for the three months ended June 30, 2022, compared to $15.6 million
Amphenol Reports Second Quarter 2022 Record Results
Amphenol Corporation (NYSE: APH) today reported second quarter 2022 results.
“We are pleased to have closed the second quarter of 2022 with record sales and Adjusted Diluted EPS, both of which
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Turning Point Brands Announces Second Quarter 2022 Results
Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables
Monro, Inc. Announces First Quarter Fiscal 2023 Financial Results
Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced financial results for its first quarter ended June 25, 2022.
First Quarter Results2
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
DGAP-Adhoc: Allgeier SE shows significant revenue and earnings growth in the first half of 2022 and confirms guidance for 2022
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Biomind Labs Appoints Former FDA Director Dr. Thomas Laughren as Medical Advisor for Clinical Trials
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
The Vanguard Group, Inc.: Brewin Dolphin Holdings plc